Biogen (BIIB) Tops Q1 EPS by 20c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. QGEN
7. CSX
8. LRCX
9. NDAQ
10. BFH

Go back to Biogen (BIIB) Tops Q1 EPS by 20c

Biogen Reports First Quarter 2017 Revenues of $2.8 Billion

April 25, 2017 6:59 AM EDT

Total revenues grew 3%, or 8% excluding hemophilia revenues*

SPINRAZA launch in the U.S. off to a strong start; Company receives positive CHMP opinion for SPINRAZA and prepares for launch in Europe

TECFIDERA U.S. patents upheld in both IPR and interference proceedings

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) today reported first quarter 2017 financial results, including:

Total revenues of $2.8 billion, a 3% increase versus the prior year and an 8% increase excluding hemophilia revenues*.... More